Lupin (LUPIN) — Announcement

📢 Key Event
Lupin reports record Q1 revenue and EBITDA growth with margin expansion

🔄 What Changed
EBITDA margin improved to 30% from 26.6% YoY, gross margin rose to 74.6%, R&D spend maintained at 7.4% of sales

🔮 What's Next
high single-digit revenue growth and ~25% EBITDA margin for full year

💡 Investor Takeaway
Strong top-line growth and margin expansion signal robust execution, but high R&D spend and U.S. pricing pressure require monitoring of profitability sustainability.

Lupin reported record Q1 FY27 revenue of INR 8,277 crores and EBITDA of INR 2,464 crores, up 32% and 50% YoY respectively, with gross margins expanding to 74.6%. The company reaffirmed full-year guidance of high single-digit revenue growth and ~25% EBITDA margins, driven by strong performance in India, the U.S., and emerging markets, alongside continued investment in R&D at 7.4% of sales.

📄 View Original Announcement (PDF)

📊 Stock Analysis — LUPIN ✨ Ask AI About This

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

💡 Ask AI about this filing

"How will U.S. pricing pressure impact future EBITDA margins?" "What is the expected timeline for biosimilars to contribute meaningful revenue?" "How does the company plan to fund innovation while reducing net cash?"

Ask AI Free →

📊 More LUPIN filings

See all LUPIN filings →

🔥 Also filed on 12 August 2026

CONSOFINVT Consolidated Finvest & Holdings Limited Corporate Action NITCO Nitco Limited Financial Results SDBL Som Distilleries & Breweries Limited Financial Results DBL Dilip Buildcon Limited Corporate Action KPIGREEN KPI Green Energy Limited Financial Results TOUCHWOOD Touchwood Entertainment Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.